Partnering With MPP

It takes a range of stakeholders to make sure medicines reach those who need them.

Why Partner With MPP

MPP would not have the same impact without our partners. It takes a range of stakeholders to make sure affordable quality medicines reach those who need them. MPP are ready to talk to you about our model and developing new collaborations to make sure no one is left behind.

Our partners include:

  • Originator companies – medicine and health technology developers, and patent holders who want to place their licence with MPP. The terms of each licence are bespoke and take into account the specific characteristics of each product and the public health needs in LMICs.
  • Generic manufacturers – those who take out a licence and develop a generic version of the product. MPP offers a range of services and technical advice, including support in the development, registration and supply of the medicines in LMICs.
  • Biotech and new actors – as new products are developed, MPP works with partners on access strategies and explores partnering options.
  • Global health stakeholders – we work with WHO and other international organisations, foundations, NGOs, civil society and patient groups. MPP partners with groups to understand public health priorities, identify access gaps and explore opportunities to increase access through MPP licences. We share the information we gather on patents and sales openly with the aim to promote transparency.
  • Governments of countries with access to licensed products – we aim for low- and middle-income countries to have access to affordable versions of the essential medicines they need. MPP licences make it possible for many LMICs to affordably treat people with quality products.

Who We Work With

Interested in knowing more, reach out to our team

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders